In-silico Studies, Synthesis, and Evaluation of Anti-inflammatory Activity
of Novel Pyrimidine Scaffold

Ganesh      Munde; Sunil      Menghani; Nilesh      Rarokar; Deweshri      Kerzare; Md. Asif   Iqbal   Chittur; Pramod      Khedekar

doi:10.2174/1570180819666220523090351

Abstract

Background: The heterocyclic nucleus pyrimidine is present in several natural and synthetic chemical analogues and has proved its broad medicinal applications. Further, pyrimidine in the form of parent structure or basic skeleton of RNA and DNA is involved in controlling the immune functioning, and in turn, inflammatory reactions.

Objective: The objective of the present study is to evaluate some novel pyrimidine analogues for antiinflammatory action.

Methods: Molecular docking studies of Indomethacin and selected analogues were carried out with the COX-2 enzyme (PDB: 4ZOL). The synthesis of derivatives of 4-Phenyl-6-(phenylamino)pyrimidine-2-ol derivatives was begun by following Perkin condensation between substituted acetanilides and substituted aromatic aldehydes to yield an intermediate, which in turn produces the required nucleus for treatment with urea. All synthesized compounds were evaluated for in vivo and in vitro anti-inflammatory activity.

Results: The docking interaction reflects a good dock score when compared with indomethacin, a potent Anti-inflammatory drug. In the majority of the compounds, pyrimidine was able to form hydrogen bonding while the rest of the part was involved in hydrophobic bonding. All compounds were synthesized in good yield and confirmed by physical and spectral studies. In vitro studies showed that compounds 5a and 5e were better at controlling inflammation than the conventional treatment Antipyrine, while in vivo data showed that compounds 5a, 5c, 5e, and 5h were better at controlling inflammation than the standard drug Antipyrine.

Conclusion: The compound with more than one electron releasing group on the aniline moiety of pyrimidine yields a decent result in the synthetic and experimental studies, but the absence of an electron withdrawing group favours stronger anti-inflammatory activity on the target.

Keywords: Pyrimidine, perkin condensation, anti-inflammatory activity, molecular docking, COX-2, heterocyclic nucleus.

« Previous Next »

Graphical Abstract

[1]
Amir, M.; Javed, S.A.; Kumar, H. Pyrimidine as antiinflammatory agent: A review. Indian J. Pharm. Sci.,  2007, 69(3), 337-343.
 [http://dx.doi.org/10.4103/0250-474X.34540]

[2]
Lagoja, I.M. Pyrimidine as constituent of natural biologically active compounds. Chem. Biodivers.,  2005, 2(1), 1-50.
 [http://dx.doi.org/10.1002/cbdv.200490173] [PMID:  17191918]

[3]
Jain, K.S.; Chitre, T.S.; Miniyar, P.B.; Kathiravan, M.K.; Bendre, V.S.; Veer, V.S.; Shahane, S.R.; Shishoo, C.J. Biological and medicinal significance of pyrimidines. Curr. Sci.,  2006, 90(6), 793-803.

[4]
Bhalgat, C.M.; Irfan Ali, M.; Ramesh, B.; Ramu, G. Novel pyrimidine and its triazole fused derivatives: Synthesis and investigation of antioxidant and anti-inflammatory activity. Arab. J. Chem.,  2014, 7(6), 986-993.
 [http://dx.doi.org/10.1016/j.arabjc.2010.12.021]

[5]
Ozair, A. Mohd. I, S. A. Khan. Synthesis and biological activity of some pyrimidine derivatives. Indian J. Heterocycl. Chem.,  2005, 14, 293-296.

[6]
Mitsuya, H.; Weinhold, K.J.; Furman, P.A.; St Clair, M.H.; Lehrman, S.N.; Gallo, R.C.; Bolognesi, D.; Barry, D.W.; Broder, S. 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA,  1985, 82(20), 7096-7100.
 [http://dx.doi.org/10.1073/pnas.82.20.7096] [PMID:  2413459]

[7]
Polak, A.; Scholer, H.J. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy,  1975, 21(3-4), 113-130.
 [http://dx.doi.org/10.1159/000221854] [PMID:  1098864]

[8]
Roth, B.; Cheng, C.C. Recent progress in the medicinal chemistry of 2,4-diaminopyrimidines. Prog. Med. Chem.,  1982, 19, 269-331.
 [http://dx.doi.org/10.1016/S0079-6468(08)70332-1] [PMID:  6129679]

[9]
Levenberg, B.; Linton, S.N. On the biosynthesis of toxoflavin, an azapteridine antibiotic produced by Pseudomonas cocovenenans. J. Biol. Chem.,  1966, 241(4), 846-852.
 [http://dx.doi.org/10.1016/S0021-9258(18)96842-0] [PMID:  5905124]

[10]
Hirshey, S.J.; Falany, C.N. Purification and characterization of rat liver minoxidil sulphotransferase. Biochem. J.,  1990, 270(3), 721-728.
 [http://dx.doi.org/10.1042/bj2700721] [PMID:  2241904]

[11]
Rupan, S.M.; Sompale, R. Synthetic chemistry of pyrimidines and fused pyrimidines: A review. An International Journal for Rapid Communication of Synthetic Organic Chemistry,  2016, 46, 645-672.

[12]
Sondhi, S.M.; Singh, N.; Johar, M.; Kumar, A. Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives. Bioorg. Med. Chem.,  2005, 13(22), 6158-6166.
 [http://dx.doi.org/10.1016/j.bmc.2005.06.063] [PMID:  16115773]

[13]
Kotha, A.; Gorla, V.; Azad, R.; Yarla, N.S.; Dharmapuri, G.; Srivastava, A. Moh. Kamal, A.; Pallu, R. Evaluation of Anti-inflammatory properties of Isoorientin Isolated from Tubes of Pueraria tuberosa. Oxid. Med. Cell. Longev.,  2017, 20175498054
 [http://dx.doi.org/10.1155/2017/5498054]

[14]
Silva, L.A. Literature Review of Inflammation and Its Relationship with the Oral Cavity. Global Journal of Infectious Diseases and Clinical Research,  2015, 2(1), 1-7.
 [http://dx.doi.org/10.17352/2455-5363.000006]

[15]
Ahmed, A.U. An overview of inflammation: mechanism and consequences. Front. Biol. (Beijing),  2011, 6(4), 274-281.
 [http://dx.doi.org/10.1007/s11515-011-1123-9]

[16]
Medzhitov, R. Origin and physiological roles of inflammation. Nature,  2008, 454(7203), 428-435.
 [http://dx.doi.org/10.1038/nature07201] [PMID:  18650913]

[17]
Iwalewa, E.O.; McGaw, L.J.; Naidoo, V.; Eloff, J.N. Inflammation: the foundation of diseases and disorders. A review of phytomedicines of South African origin used to treat pain and inflammatory conditions. African J. Biotechnol.,  2007, 6(25), 2868-2885.

[18]
Buttgereit, F.; Burmester, G.R.; Simon, L.S. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors. Am. J. Med.,  2001, 110(3A)(Suppl. 3A), 13S-19S.
 [http://dx.doi.org/10.1016/S0002-9343(00)00728-2] [PMID:  11173045]

[19]
Asghar, W.; Jamali, F. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. Inflammopharmacology,  2015, 23(1), 1-16.
 [http://dx.doi.org/10.1007/s10787-014-0225-9] [PMID:  25515365]

[20]
Rosenbloom, D.; Craven, M.A. A review of non-steroidal anti-inflammatory drugs. Can. Fam. Physician,  1983, 29, 2121-2124.
 [PMID:  21283472]

[21]
Patil, A.D.; Surana, S.J. Synthesis, biological evaluation and molecular docking of 2,3-disubstituted-thiazolyl-quinazolin-4(3H)-one derivatives. J. Pharm. Sci. Pharmacol.,  2015, 2(1), 35-46.
 [http://dx.doi.org/10.1166/jpsp.2015.1040]

[22]
Zhou, J.P.; Ding, Y.W.; Zhang, H.B.; Xu, L.; Dai, Y. Synthesis and anti-inflammatory activity of imidazo[1,2-a]pyrimidine derivatives. Chin. Chem. Lett.,  2008, 19(6), 669-672.
 [http://dx.doi.org/10.1016/j.cclet.2008.04.020]

[23]
Giles, D.; Roopa, K.; Sheeba, F.R.; Gurubasavarajaswamy, P.M.; Divakar, G.; Vidhya, T. Synthesis pharmacological evaluation and docking studies of pyrimidine derivatives. Eur. J. Med. Chem.,  2012, 58, 478-484.
 [http://dx.doi.org/10.1016/j.ejmech.2012.09.050] [PMID:  23159805]

Rights & Permissions Print Cite

Article Metrics

1

Explore Articles

Open Access

Open Access Articles

DOI https://dx.doi.org/10.2174/1570180819666220523090351	Print ISSN 1570-1808
Publisher Name Bentham Science Publisher	Online ISSN 1875-628X

Letters in Drug Design & Discovery

In-silico Studies, Synthesis, and Evaluation of Anti-inflammatory Activity of Novel Pyrimidine Scaffold

Abstract Play Pause

Graphical Abstract

Abstract